Roche and Prothena are advancing Prasinezumab to Phase 3 for Parkinson’s despite mixed Phase 2 results. Click here to read an ...

With fewer than 200 trained dermatologists serving Malaysia's 33 million people[1]-just one specialist for every 165,000 ...

Venclexta, when combined with azacitidine, elicited an overall survival benefit below 10% in patients with myelodysplastic ...

In rare public comments, WA's Public Trustee tells a parliamentary committee the government should consider subsidising the ...

Prothena Corporation plc (NASDAQ:PRTA) is an Ireland-based late-stage clinical biotechnology company that identifies and ...

AbbVie is deploying more capital into its pipeline, which features 50 programs in mid- and late-stage development and over ...

Featuring works from Chelsea Odufu, Laurena Finéus, Jarrett Key, and more, the show challenges how we encounter personal ...

Whyte, 18, a popular Tiktok creator, had 100,00 followers and his account was flooded with over 4,000 comments in the days after his death, including many wishing him a heavenly 19th birthday on ...

In late May, Saanich student Nathan Hellner-Mestelman received the TD Scholarship for Community Leadership – an award coveted ...

Other appointments to BIO's board for the 2025 through 2026 term include: Arcutis Bio's Frank Watanabe, named vice-chair; ...

At the Heart in Diabetes CME Conference, speakers highlighted four recent reports published in the Journal of the American ...

An ESSENCE beauty editor prefers pharmacy skincare over expensive, buzzword products—here's why.